OCD

The Neuropsychiatric Pipeline: 10 Late-Stage Therapies to Watch
BioSpace
Mon, 08/14/23 - 11:23 am
depression
Biogen
SAGE Therapeutics
zuranolone
Intra-Cellular Therapies
lumateperone
Alto Neuroscience
ALTO-100
schizophrenia
Karuna Therapeutics
KarXT
Cerevel Therapeutics
emraclidine
Acadia Pharmaceuticals
pimavanserin
Axesome Therapeutics
AXS-05
Alzheimer's agitation
NRx
NRX-101
bipolar disorder
Biohaven
troriluzole
OCD
VistaGen
fasedienol
social anxiety
Biohaven fails OCD trial but pushes on to phase 3 regardless
Fierce Biotech
Wed, 06/24/20 - 10:54 am
Biohaven
OCD
clinical trials
troriluzole
For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials
Forbes
Tue, 02/11/20 - 11:49 pm
artificial intelligence
OCD
drug development
DSP-1181
Sumitomo Dainippon
Exscientia
FDA approves Brainsway’s transcranial magnetic stimulator
GoinPharma
Mon, 08/27/18 - 10:49 pm
Brainsway
FDA
devices
Deep Transcranial Magnetic Stimulation
OCD
Brainsway wins FDA nod for OCD-treating TMS system
Mass Device
Fri, 08/17/18 - 09:22 pm
devices
Brainsway
TMS
OCD
Transcept caps a tough year with PhII drug failure
Fierce Biotech
Sat, 12/22/12 - 12:54 pm
Transcept
TO-2061
OCD
Transcept caps a tough year with PhII drug failure
Fierce Biotech
Fri, 12/21/12 - 10:56 am
Transcept
TO-2061
OCD
More to Transcept than Intermezzo
Yahoo/Zacks.com
Thu, 06/10/10 - 09:28 am
Intermezzo
Transcept
GSK
insomnia
OCD